{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:51Z","timestamp":1790616471116,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"name":"W. Jim\u00e9nez from Direcci\u00f3n General de Investigaci\u00f3n Cient\u00edfica y T\u00e9cnica","award":["SAF12-35979"],"award-info":[{"award-number":["SAF12-35979"]}]},{"name":"Ferring Research Institute"},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>\n                    Patients and rats with cirrhosis and ascites have portal hypertension and circulatory dysfunction. Synthetic arginine vasopressin (AVP) receptor agonists able to induce systemic and mesenteric vasoconstriction have shown their usefulness in reducing portal pressure (PP) in this condition. We assessed the potential therapeutic value of a new V\n                    <jats:sub>1<\/jats:sub>\n                    <jats:sub>a<\/jats:sub>\n                    \u2010AVP receptor partial agonist with a preferential splanchnic vasoconstrictor effect (FE\u00a0204038) in rats with cirrhosis and ascites. The hemodynamic effects of cumulative intravenous doses of FE 204038, terlipressin, or vehicle were investigated. Mean arterial pressure and PP were continuously recorded and cardiac output and systemic vascular resistance (SVR) assessed at 30\u2010minute intervals for 90 minutes. Urine volume, urine osmolality, and urinary excretion of sodium and creatinine were measured in basal conditions and following twice\u2010daily subcutaneous doses of FE 204038 or vehicle. PP, mean arterial pressure, cardiac output, SVR, and ascites volume were also measured after 6 days. The expression of an array of vasoactive genes was assessed in the thoracic aorta and the mesenteric circulation of control rats and rats with cirrhosis and ascites. FE 204038 dose\u2010dependently decreased PP, did not modify mean arterial pressure, and increased SVR. The effect of the V\n                    <jats:sub>1a<\/jats:sub>\n                    \u2010AVP receptor partial agonist on PP was associated with an improvement in urine volume and urinary excretion of sodium during the first day of treatment. SVR was higher and cardiac output and ascites volume were lower in rats with cirrhosis and ascites treated with FE\u00a0204038. V\n                    <jats:sub>1a<\/jats:sub>\n                    \u2010AVP receptor expression in rats with cirrhosis and ascites was markedly enhanced in the mesenteric circulation compared to the thoracic aorta.\n                    <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                    FE\u00a0204038 increases sodium excretion and reduces portal hypertension and ascites in experimental cirrhosis. V\n                    <jats:sub>1a<\/jats:sub>\n                    \u2010AVP receptor partial agonism could be a useful pharmacological treatment in decompensated patients with cirrhosis. (H\n                    <jats:sc>epatology<\/jats:sc>\n                    2016;63:207\u2013216)\n                  <\/jats:p>","DOI":"10.1002\/hep.28250","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T20:42:47Z","timestamp":1443127367000},"page":"207-216","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats"],"prefix":"10.1097","volume":"63","author":[{"given":"Guillermo","family":"Fern\u00e1ndez\u2010Varo","sequence":"first","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"},{"name":"Department Ciencies Fisiologiques I,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Or\u00f3","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Earl","family":"Cable","sequence":"additional","affiliation":[{"name":"Ferring Research Institute Inc.,San Diego,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedrana","family":"Reichenbach","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Carvajal","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino Gonz\u00e1lez","family":"de la Presa","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Wi\u015bniewski","sequence":"additional","affiliation":[{"name":"Ferring Research Institute Inc.,San Diego,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e9s","sequence":"additional","affiliation":[{"name":"Liver Unit, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Harris","sequence":"additional","affiliation":[{"name":"Ferring Research Institute Inc.,San Diego,CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wladimiro","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Genetics Service, Hospital Cl\u00ednic i Provincial de Barcelona, IDIBAPS, CIBERehd,University of Barcelona,Barcelona,Spain"},{"name":"Department Ciencies Fisiologiques I,University of Barcelona,Barcelona,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"hep28250-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"hep28250-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1742-7843.2006.pto_299.x","article-title":"The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease","volume":"99","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"hep28250-bib-0005-20241017","first-page":"332","article-title":"The treatment of portal hypertension: a meta\u2010analytic review","volume":"22","year":"1995","journal-title":"Hepatology"},{"key":"hep28250-bib-0006-20241017","first-page":"399","article-title":"Pharmacological treatment of portal hypertension: an evidence\u2010based approach","volume":"20","year":"2000","journal-title":"Semin Liver Dis"},{"key":"hep28250-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Vasopressin and the cardiovascular system part 1\u2014receptor physiology","volume":"7","year":"2003","journal-title":"Crit Care"},{"key":"hep28250-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0022-3565(25)23348-1","article-title":"Human vascular vasopressin receptors: analysis with selective vasopressin receptor antagonists","volume":"239","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"hep28250-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(25)30159-X","article-title":"Dose\u2010response relationships for arginine vasopressin and synthetic analogs on three types of rat blood vessels: possible evidence for regional differences in vasopressin receptor sites within a mammal","volume":"193","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"hep28250-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.135764","article-title":"Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance","volume":"325","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"hep28250-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","year":"1997","journal-title":"J Hepatol"},{"key":"hep28250-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1746.2004.03226.x","article-title":"Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study","volume":"19","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"hep28250-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/BF01535785","article-title":"Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl\u2010lysin\u2010vasopressin administration in alcoholic cirrhosis","volume":"33","year":"1988","journal-title":"Dig Dis Sci"},{"key":"hep28250-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients","volume":"20","year":"2000","journal-title":"Liver"},{"key":"hep28250-bib-0015-20241017","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hep.510270206","article-title":"Effects of F\u2010180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension","volume":"27","year":"1998","journal-title":"Hepatology"},{"key":"hep28250-bib-0016-20241017","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1053\/jhep.2003.09023","article-title":"Effects of the V1a vasopressin agonist F\u2010180 on portal hypertension\u2010related bleeding in portal hypertensive rats","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep28250-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1572-0241.2005.41381.x","article-title":"Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison","volume":"100","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"hep28250-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"hep28250-bib-0019-20241017","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.23893","article-title":"Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"hep28250-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jhep.2012.07.012","article-title":"Adenoviral dominant\u2010negative soluble PDGFRb improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep28250-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2010.08.001","article-title":"Renal and circulatory dysfunction in cirrhosis: current management and future perspectives","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep28250-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2010.05.031","article-title":"Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"hep28250-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/ki.2010.4","article-title":"Afferent mechanisms of sodium retention in cirrhosis and hepatorenal syndrome","volume":"77","year":"2010","journal-title":"Kidney Int"},{"key":"hep28250-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/00365520902912555","article-title":"Ascites: pathogenesis and therapeutic principles","volume":"44","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl. 1","key":"hep28250-bib-0026-20241017","first-page":"157","article-title":"Renal and circulatory dysfunction in cirrhosis. Lights and shadows in an important clinical problem","volume":"32","year":"2000","journal-title":"J Hepatol"},{"key":"hep28250-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00004872-198809000-00006","article-title":"Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion","volume":"6","year":"1988","journal-title":"J Hypertens"},{"issue":"6","key":"hep28250-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"H2227","DOI":"10.1152\/ajpheart.00588.2011","article-title":"Differential effects of eNOS uncoupling on conduit and small arteries in GTP\u2010cyclohydrolase I\u2010deficient hph\u20101 mice","volume":"301","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"hep28250-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"17167","DOI":"10.1073\/pnas.252345399","article-title":"NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase","volume":"99","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"hep28250-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FJC.0b013e3181c87a82","article-title":"Effects of olmesartan on Apelin\/APJ and Akt\/endothelial nitric oxide synthase pathway in Dahl rats with end\u2010stage heart failure","volume":"55","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"hep28250-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.111.188078","article-title":"Prevention of fibrosis progression in CCl4\u2010treated rats: role of the hepatic endocannabinoid and apelin systems","volume":"340","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"hep28250-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/0016-5085(95)90148-5","article-title":"Endothelin\u20101 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites","volume":"108","year":"1995","journal-title":"Gastroenterology"},{"key":"hep28250-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0168-8278(01)00141-6","article-title":"Role of small\u2010conductance Ca2+\u2010dependent K+ channels in in vitro nitric oxide\u2010mediated aortic hyporeactivity to alpha\u2010adrenergic vasoconstriction in rats with cirrhosis","volume":"35","year":"2001","journal-title":"J Hepatol"},{"key":"hep28250-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/hep.510240630","article-title":"Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites","volume":"24","year":"1996","journal-title":"Hepatology"},{"key":"hep28250-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1478-3231.2005.01092.x","article-title":"The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites","volume":"25","year":"2005","journal-title":"Liver Int"},{"issue":"1","key":"hep28250-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0016-5085(99)70240-4","article-title":"Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects","volume":"116","year":"1999","journal-title":"Gastroenterology"},{"key":"hep28250-bib-0038-20241017","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.22467","article-title":"The hepatic apelin system: a new therapeutic target for liver disease","volume":"48","year":"2008","journal-title":"Hepatology"},{"key":"hep28250-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MCC.0b013e328335a35b","article-title":"The effects of vasopressin and its analogues on the liver and its disorders in the critically ill","volume":"16","year":"2010","journal-title":"Curr Opin Crit Care"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28250","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28250","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:11:02Z","timestamp":1748621462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201601000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28250","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725809468.793510932","asserted-by":"object"}]},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"assertion":[{"value":"2015-05-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-09-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}